Lange PH - Search Results

1

Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.

Brown JM, Vessella RL, Kostenuik PJ, Dunstan CR, Lange PH, Corey E. Brown JM, et al. Among authors: lange ph. Clin Cancer Res. 2001 Oct;7(10):2977-83. Clin Cancer Res. 2001. PMID: 11595685

2

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration.

Liu AY, Corey E, Bladou F, Lange PH, Vessella RL. Liu AY, et al. Among authors: lange ph. Int J Cancer. 1996 Jan 3;65(1):85-9. doi: 10.1002/(SICI)1097-0215(19960103)65:1<85::AID-IJC15>3.0.CO;2-H. Int J Cancer. 1996. PMID: 8543402

3

Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.

Corey E, Wegner SK, Stray JE, Corey MJ, Arfman EW, Lange PH, Vessella RL. Corey E, et al. Among authors: lange ph. Int J Cancer. 1997 Jun 11;71(6):1019-28. doi: 10.1002/(sici)1097-0215(19970611)71:6<1019::aid-ijc18>3.0.co;2-8. Int J Cancer. 1997. PMID: 9185706

4

Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.

Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG. Ellis WJ, et al. Among authors: lange ph. Urology. 1997 Oct;50(4):573-9. doi: 10.1016/S0090-4295(97)00251-3. Urology. 1997. PMID: 9338734 Clinical Trial.

5

The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.

Ellis WJ, Vessella RL, Corey E, Arfman EW, Oswin MM, Melchior S, Lange PH. Ellis WJ, et al. Among authors: lange ph. J Urol. 1998 Apr;159(4):1134-8. J Urol. 1998. PMID: 9507816

6

Serum percent free prostate-specific antigen in metastatic prostate cancer.

Lin DW, Noteboom JL, Blumenstein BA, Ellis WJ, Lange PH, Vessella RL. Lin DW, et al. Among authors: lange ph. Urology. 1998 Sep;52(3):366-71. doi: 10.1016/s0090-4295(98)00240-4. Urology. 1998. PMID: 9730445

7

Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

Melchior SW, Corey E, Ellis WJ, Ross AA, Layton TJ, Oswin MM, Lange PH, Vessella RL. Melchior SW, et al. Among authors: lange ph. Clin Cancer Res. 1997 Feb;3(2):249-56. Clin Cancer Res. 1997. PMID: 9815680

8

Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.

Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH. Ellis WJ, et al. Among authors: lange ph. Clin Cancer Res. 1996 Jun;2(6):1039-48. Clin Cancer Res. 1996. PMID: 9816265

9

Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone.

Lange PH, Vessella RL. Lange PH, et al. Cancer Metastasis Rev. 1998-1999;17(4):331-6. doi: 10.1023/a:1006106209527. Cancer Metastasis Rev. 1998. PMID: 10453276 Review.

10

Differential expression of osteonectin/SPARC during human prostate cancer progression.

Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL. Thomas R, et al. Among authors: lange ph. Clin Cancer Res. 2000 Mar;6(3):1140-9. Clin Cancer Res. 2000. PMID: 10741745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters